Garden State Urology
Mountain Lakes, New Jersey, 07046, United States
NCT Number: NCT06530186
LiviWell has developed a product designed for postcoital semen absorption. Previous studies have demonstrated the product rapidly absorbs semen, and leads to less symptoms of postcoital vaginal microbiome disruption such as vaginal odor and discharge. This study will investigate the study device, Livi, in a broader clinical setting.
Trial opening soon.
Get Notified18 year and older
Female
Interventional
Not applicable
Mountain Lakes, New Jersey, 07046, United States
LiviWell's consumer hygiene device is a post-coital vaginal insert called "Livi". Livi is comprised of an applicator, with a medical-grade polyurethane foam and retrieval string. It is designed to be inserted into the vagina after intercourse to absorb semen deposited into the vaginal canal. The result is a decrease in discharge/dripping and vaginal odor. The investigators also believe the device will lower vaginal pH, as the typical premenopausal vaginal pH is acidic (pH ~4), and semen has an alkaline pH (~8). The resulting pH imbalance in sexually-active women not using male condoms had been shown to lead to vaginal odor, dripping, discomfort. Furthermore, the risk of bacterial vaginosis (BV) is higher in women who are sexually active and not using male condoms. The investigators have additional studies planned to evaluate if the product lowers the risk of BV.
The current study will be used to validate user needs requirements for the study device, understand pH changes after insertion, and evaluate change in symptoms of vaginal odor, discharge/dripping, and discomfort, common symptoms of vaginal microbiome disruption and bacterial vaginosis.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
subjects will use Livi within minutes of completion of sex, and will remove study device in under an hour.
Other names: Livi
Time frame: 24 hours
Validation of User Needs Requirements as well as patient experience
Time frame: 2-6 hours, and 10-14 hours after use
change in vaginal pH before and after using Livi, and before and after NOT using Livi
Atlantic Health System
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01055106
Bacterial Infections, Bacterial Infections and Mycoses
Phoenix, Arizona, United States
View Trial DetailsNCT03372395
ASC-US, Atypical Squamous Cells of the Cervix
View Trial DetailsNCT03532464
Anal Infection, Chlamydia Trachomatis Infection
Marseille, Marignane, France
View Trial DetailsNCT03261804
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Asyut, Egypt
View Trial Details